Prevalence of methylenetetrahydrofolate reductase mutations in patients with venous thrombosis. (Q54733446)

3 June 2018

title

Prevalence of methylenetetrahydrofolate reductase mutations in patients with venous thrombosis. (English)

1 reference

3 June 2018

0 references

Isotalo PA

1

1 reference

3 June 2018

Donnelly JG

series ordinal

2

1 reference

3 June 2018

publication date

1 March 2000

1 reference

3 June 2018

Molecular Diagnosis and Therapy

published in

1 reference

3 June 2018

volume

5

1 reference

3 June 2018

issue

1

1 reference

3 June 2018

page(s)

59-66

1 reference

3 June 2018

High frequency (71%) of cystathionine β-synthase mutation G307S in Irish homocystinuria patients

cites work

1 reference

12 December 2020

Clinical chemistry and molecular biology of homocysteine metabolism: an update

1 reference

12 December 2020

Oral contraceptives and thrombotic disease: risk of venous thromboembolism

1 reference

12 December 2020

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

1 reference

12 December 2020

Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis

1 reference

12 December 2020

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

12 December 2020

Risk of Venous Thrombosis in Carriers of a Common Mutation in the Homocysteine Regulatory Enzyme Methylenetetrahydrofolate Reductase

1 reference

12 December 2020

Homocysteine metabolism in pregnancies complicated by neural-tube defects

1 reference

12 December 2020

Hyperhomocyst(e)inemia and atherothrombosis

1 reference

12 December 2020

Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss

1 reference

12 December 2020

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

1 reference

12 December 2020

Hyperhomocysteinemia and venous thromboembolic disease

1 reference

12 December 2020

The inherited basis of venous thrombosis

1 reference

12 December 2020

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis

1 reference

12 December 2020

Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

1 reference

12 December 2020

Acute hyperhomocysteinaemia and endothelial dysfunction

1 reference

12 December 2020

Hyperhomocysteinemia: an independent risk factor for vascular disease

1 reference

12 December 2020

Mutated 5,10-methylenetetrahydrofolate reductase and moderate hyperhomocysteinaemia

1 reference

12 December 2020

A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

1 reference

12 December 2020

The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.

1 reference

12 December 2020

A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity

1 reference

12 December 2020

Genetic determinants of heritable venous thrombosis: genotyping methods for factor V(Leiden)A1691G, methylenetetrahydrofolate reductase C677T, prothrombin G20210A mutation, and algorithms for venous thrombosis investigations.

1 reference

12 December 2020

C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients

1 reference

12 December 2020

Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida

1 reference

12 December 2020

Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells

1 reference

12 December 2020

Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group

1 reference

12 December 2020

Elevated homocyst(e)ine levels with preeclampsia

1 reference

12 December 2020

Decreased proportion of female newborn infants homozygous for the 677 C-->T mutation in methylenetetrahydrofolate reductase

1 reference

12 December 2020

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

1 reference

12 December 2020

Non-fasting reference intervals for the Abbott IMx homocysteine and AxSYM plasma folate assays: influence of the methylenetetrahydrofolate reductase 677 C-->T mutation on homocysteine.

1 reference

12 December 2020

10.1016/S1084-8592(00)00012-6

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018